Back
Santhera Pharmaceuticals Holding AG Vs. John Wiley & Sons, Inc. Industry Stock Comparison
Sell
48
SPHDF
Santhera Pharmaceuticals Holding AG
Last Price:
$19.60
Seasonality Move:
7.29%
Sell
48
WLY
John Wiley & Sons, Inc.
Last Price:
$39.06
Seasonality Move:
2.3%
Sell
48
Santhera Pharmaceuticals Holding AG (SPHDF)
is a Sell
Is Santhera Pharmaceuticals Holding AG a Buy, Sell or Hold?
-
The current Santhera Pharmaceuticals Holding AG [SPHDF] share price is $19.60. The Score for SPHDF is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
SPHDF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
John Wiley & Sons, Inc. (WLY)
is a Sell
Is John Wiley & Sons, Inc. a Buy, Sell or Hold?
-
The current John Wiley & Sons, Inc. [WLY] share price is $39.05. The Score for WLY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
WLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPHDF Stock Price Chart
What is Santhera Pharmaceuticals Holding AG's stock price today?
-
The Santhera Pharmaceuticals Holding AG share price today is $19.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPHDF is experiencing slight buying pressure.
WLY Stock Price Chart
What is John Wiley & Sons, Inc.'s stock price today?
-
The John Wiley & Sons, Inc. share price today is $39.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WLY is experiencing slight buying pressure.
SPHDF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.14 | Buy |
| Relative Strength Index (14 RSI): | 53.08 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.83 - 20.97) | Sell |
| Bollinger Bands (100): | (12.83 - 19.23) | Buy |
WLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.59 | Buy |
| Relative Strength Index (14 RSI): | 74.18 | Buy |
| Chaikin Money Flow: | 61716 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.54 - 38.56) | Buy |
| Bollinger Bands (100): | (29.93 - 36.01) | Buy |
SPHDF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.37 | Buy |
| 20-day SMA: | 19.59 | Buy |
| 50-day SMA: | 18.78 | Buy |
| 200-day SMA: | 15.9 | Buy |
| 8-day EMA: | 18.46 | Buy |
| 20-day EMA: | 13.44 | Buy |
| 50-day EMA: | 7.3 | Buy |
| 200-day EMA: | 2.16 | Buy |
WLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.98 | Buy |
| 20-day SMA: | 37.2 | Buy |
| 50-day SMA: | 33.04 | Buy |
| 200-day SMA: | 36.42 | Buy |
| 8-day EMA: | 38.05 | Buy |
| 20-day EMA: | 36.63 | Buy |
| 50-day EMA: | 34.52 | Buy |
| 200-day EMA: | 35.92 | Buy |
Santhera Pharmaceuticals Holding AG Earnings Growth & SPHDF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
John Wiley & Sons, Inc. Earnings Growth & WLY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.55 per share.
Santhera Pharmaceuticals Holding AG Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
John Wiley & Sons, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||